Deals & Exits

While early and late stage VC-backed businesses are poised to weather this period of uncertainty, companies at the Series B and C stages may be left behind.

It has become an important source of capital for start-ups in recent years. But corporate investing will likely pull back substantially during the downturn.

Telemedicine valuations will rise following substantial adoption growth, and investors see a compelling thesis around these services even after coronavirus fears abate.

As remote learning takes over the world, VC-backed services that help students in a virtual environment take on new significance.

Is the security sector recession-proof? Perhaps so, given that investors point to a growing need for protection, especially for solutions that keep a remote workforce safe.

Analysts predict a global seed slowdown of 22% by the end of Q1 because of the covid-19 outbreak, US seed investors say not so fast. 

Areas of the healthcare industry will likely be triggered into action, spurring innovation, as bottlenecks in the system become increasingly clear amid covid-19, says the venture and growth-equity investor.

Venture funds should sell for about 60 percent of their net asset value today versus about 78 percent of NAV in December, according to a poll by Setter Capital.

VCs predict a swath of new technology start-ups this decade as the network continues to roll out.

The North American market saw more than C$6.2 billion flow into the region last year.